TY - JOUR
T1 - Frequency of known mutations in early-onset Parkinson disease
T2 - Implication for genetic counseling: The consortium on risk for early onset Parkinson disease study
AU - Alcalay, Roy N.
AU - Caccappolo, Elise
AU - Mejia-Santana, Helen
AU - Tang, Ming Xin
AU - Rosado, Llency
AU - Ross, Barbara M.
AU - Verbitsky, Miguel
AU - Kisselev, Sergey
AU - Louis, Elan D.
AU - Comella, Cynthia
AU - Colcher, Amy
AU - Jennings, Danna
AU - Nance, Martha A.
AU - Bressman, Susan B.
AU - Scott, William K.
AU - Tanner, Caroline
AU - Mickel, Susan
AU - Andrews, Howard
AU - Waters, Cheryl
AU - Fahn, Stanley
AU - Cote, Lucien
AU - Frucht, Steven
AU - Ford, Blair
AU - Rezak, Michael
AU - Novak, Kevin
AU - Friedman, Joseph H.
AU - Pfeiffer, Ronald
AU - Marsh, Laura
AU - Hiner, Bradley
AU - Siderowf, Andrew
AU - Ottman, Ruth
AU - Marder, Karen
AU - Clark, Lorraine N.
PY - 2010/9
Y1 - 2010/9
N2 - Objective: To assess the frequency and clinical characteristics of carriers of previously identified mutations in 6 genes associated with early-onset Parkinson disease (PD) and provide empirical data that can be used to inform genetic counseling. Design: Cross-sectional observational study. Setting: Thirteen movement disorders centers. Patients: Nine hundred fifty-three individuals with early-onset PD defined as age at onset (AAO) younger than 51 years. Participants included 77 and 139 individuals of Hispanic and Jewish ancestry, respectively. Intervention: Mutations in SNCA, PRKN, PINK1, DJ1, LRRK2, and GBA were assessed. A validated family history interview and the Unified Parkinson Disease Rating Scale were administered. Demographic and phenotypic characteristics were compared among groups defined by mutation status. Main Outcome Measure: Mutation carrier frequency stratified by AAO and ethnic background. Results: One hundred fifty-eight (16.6%) participants had mutations, including 64 (6.7%) PRKN, 35 (3.6%) LRRK2 G2019S, 64 (6.7%) GBA, and 1 (0.2%) DJ1. Mutation carriers were more frequent in those with an AAO of 30 years or younger compared with those with AAO between 31 and 50 years (40.6% vs 14.6%, P<.001), in individuals who reported Jewish ancestry (32.4% vs 13.7%, P<.001), and in those reporting a first-degree family history of PD(23.9% vs 15.1%, P=.01). Hispanic individuals were more likely to be PRKN carriers than non-Hispanic individuals (15.6% vs 5.9%, P=.003). The GBA L444P mutation was associated with a higher mean Unified Parkinson Disease Rating Scale III score after adjustment for covariates. Conclusion: Individuals of Jewish or Hispanic ancestry with early-onset PD, those with AAO of 30 years or younger, and those with a history of PD in a first-degree relative may benefit from genetic counseling.
AB - Objective: To assess the frequency and clinical characteristics of carriers of previously identified mutations in 6 genes associated with early-onset Parkinson disease (PD) and provide empirical data that can be used to inform genetic counseling. Design: Cross-sectional observational study. Setting: Thirteen movement disorders centers. Patients: Nine hundred fifty-three individuals with early-onset PD defined as age at onset (AAO) younger than 51 years. Participants included 77 and 139 individuals of Hispanic and Jewish ancestry, respectively. Intervention: Mutations in SNCA, PRKN, PINK1, DJ1, LRRK2, and GBA were assessed. A validated family history interview and the Unified Parkinson Disease Rating Scale were administered. Demographic and phenotypic characteristics were compared among groups defined by mutation status. Main Outcome Measure: Mutation carrier frequency stratified by AAO and ethnic background. Results: One hundred fifty-eight (16.6%) participants had mutations, including 64 (6.7%) PRKN, 35 (3.6%) LRRK2 G2019S, 64 (6.7%) GBA, and 1 (0.2%) DJ1. Mutation carriers were more frequent in those with an AAO of 30 years or younger compared with those with AAO between 31 and 50 years (40.6% vs 14.6%, P<.001), in individuals who reported Jewish ancestry (32.4% vs 13.7%, P<.001), and in those reporting a first-degree family history of PD(23.9% vs 15.1%, P=.01). Hispanic individuals were more likely to be PRKN carriers than non-Hispanic individuals (15.6% vs 5.9%, P=.003). The GBA L444P mutation was associated with a higher mean Unified Parkinson Disease Rating Scale III score after adjustment for covariates. Conclusion: Individuals of Jewish or Hispanic ancestry with early-onset PD, those with AAO of 30 years or younger, and those with a history of PD in a first-degree relative may benefit from genetic counseling.
UR - http://www.scopus.com/inward/record.url?scp=77957043835&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77957043835&partnerID=8YFLogxK
U2 - 10.1001/archneurol.2010.194
DO - 10.1001/archneurol.2010.194
M3 - Article
C2 - 20837857
AN - SCOPUS:77957043835
SN - 0003-9942
VL - 67
SP - 1116
EP - 1122
JO - Archives of neurology
JF - Archives of neurology
IS - 9
ER -